ncq 298 has been researched along with 5-bromo-2,3-dimethoxy-n-((1-(4-fluorobenzyl)-2-pyrrolidinyl)methyl)benzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Farde, L; Hall, H; Halldin, C; Högberg, T; Larsson, S; Sedvall, G | 1 |
1 review(s) available for ncq 298 and 5-bromo-2,3-dimethoxy-n-((1-(4-fluorobenzyl)-2-pyrrolidinyl)methyl)benzamide
Article | Year |
---|---|
Imaging of dopamine receptors using PET and SPECT.
Topics: Animals; Benzamides; Brain; Dopamine Agonists; Dopamine Antagonists; Humans; Macaca fascicularis; Pyrrolidines; Raclopride; Receptors, Dopamine; Salicylamides; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1992 |